Showing 121-140 of 258 for: EBMG evidence summaries > Pharmacotherapeutics 
- Different quinolones for uncomplicated acute cystitis in women
EBMG evidence summaries, 26-Apr-2007
Different quinolones have similar clinical efficacy for acute cystitis in women but some differences in safety.
- Different routes of administration of non-steroidal anti-inflammatory drugs
EBMG evidence summaries, 5-Aug-2003
In renal colic NSAIDs appear to act quickest when given intravenously. In all other pain conditions there is a lack of evidence of any difference between routes.
- Dipyrone for acute renal colic pain
EBMG evidence summaries, 6-Feb-2003
Single dose dipyrone appears to have similar efficacy to other analgesics used in renal colic pain.
- Diuretics for heart failure
EBMG evidence summaries, 17-Mar-2009
Conventional diuretics appear to reduce the risk of death and worsening heart failure compared to placebo in patients with chronic heart failure. Compared to active control, diuretics appear to improve exercise capacity.
- Diuretics or beta-blockers as first line therapy for hypertension in the elderly?
EBMG evidence summaries, 20-Mar-2003
Diuretics, but not beta-blockers, appear to reduce all-cause mortality in elderly patients with hypertension. Both reduce cerebrovascular events.
- Drug interactions with azole antifungal agents
EBMG evidence summaries, 5-Aug-2003
Azole antifungals appear to have serious interactions with anti-histamines and cisapride. The doses of some other drugs should be decreased if used concomitantly with azole antifungals.
- Effect of oral and inhaled corticosteroids on growth in children with asthma
EBMG evidence summaries, 10-Jan-2006
Oral prednisone and inhaled beclomethasone used for treating asthma have a growth-retarding effect in children.
- Efficacy and safety of cholesterol lowering by statins
EBMG evidence summaries, 22-Aug-2008
Statin therapy safely reduces the incidence of major coronary events, coronary revascularisation, and stroke by about one fifth per mmol/l reduction in LDL cholesterol, largely irrespective of the initial lipid profile.
- Facilitated percutaneous coronary intervention (PCI) vs PCI alone
EBMG evidence summaries, 21-Apr-2007
Facilitated percutaneous coronary intervention, particularly by thrombolytic therapy, increases mortality, reinfarction, urgent revascularisation and bleeding.
- Fiber supplements as treatment for hemorrhoids
EBMG evidence summaries, 25-Apr-2006
Fiber supplements in the diet appear to relieve overall symptoms and bleeding from symptomatic hemorrhoids.
- Fibrinolytic therapy for intraventricular hemorrhage in adults
EBMG evidence summaries, 13-Jan-2010
There is no evidence from controlled trials of the safety and efficacy of fibrinolytic therapy for intraventricular hemorrhage.
- Fluids and diuretics for acute ureteric colic
EBMG evidence summaries, 5-Dec-2005
Fluid therapy might possibly not be effective for pain or for reducing the need for stone removal in adults with uncomplicated acute ureteric colic, but there is insufficient evidence from controlled trials.
- Fluoroquinolones and the risk of Achilles tendon disorders
EBMG evidence summaries, 5-Aug-2003
Fluoroquinolones may increase the risk of Achilles tendon disorders in people aged 60 and over. Concomitant use of corticosteroids may increase the risk.
- Fluoroquinolones for treating tuberculosis
EBMG evidence summaries, 30-Apr-2008
Substituting or adding fluoroquinolones to established first-line antituberculous drug regimens gives no additional benefits. In HIV-positive patients, ciprofloxacin appears to increase the incidence of relapses in drug-sensitive tuberculosis.
- Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever)
EBMG evidence summaries, 23-Sep-2009
Fluoroquinolones appear to have similar effects on clinical and microbiological failure as other antibiotics in the treatment of typhoid and paratyphoid fever. Studies on children are few.
- Fluvoxamine versus other anti-depressive agents for depression
EBMG evidence summaries, 26-May-2010
The short-term effect of fluvoxamine might possibly not be different from other antidepressants in depression, but gastrointestinal side effects might possibly be more common, although the evidence is insufficient.
- Fondaparinux in the prevention of venous thromboembolism after surgery
EBMG evidence summaries, 2-May-2006
Postoperative fondaparinux is more effective than perioperative enoxaparin in major orthopaedic surgery and at least as effective as dalteparin in major abdominal surgery in the prevention of venous thromboembolism in high-risk patients.
- Glucocorticosteroids for primary biliary cirrhosis
EBMG evidence summaries, 28-Dec-2005
There is insufficient evidence on the effects of glucocorticosteroids for primary biliary cirrhosis.
- Glucocorticosteroids for viral hepatitis C
EBMG evidence summaries, 22-Jul-2006
Glucocorticoids for up to 6 months are probably not effective for chronic viral hepatitis C.
- Glucocorticosteroids or D-penicillamine for primary sclerosing cholangitis
EBMG evidence summaries, 19-Apr-2010
There is no evidence to support or refute the use of peroral glucocorticosteroids or D-penicillamine for patients with primary sclerosing cholangitis.
